A researcher works in the lab at the Moderna Inc. headquarters in Cambridge, Massachusetts, US, on Tuesday, March 26, 2024.
Adam Glanzman | Bloomberg | Getty Images
Norovirus is raging across the U.S. this winter. Moderna might soon have a vaccine for it.
A large phase three trial of the shot is underway, with results expected as soon as later this year or 2026. Moderna needs to see a certain number of cases before it can analyze the data and determine how well its vaccine works, putting the timeline in flux. The 25,000-person study is enrolling ahead of schedule, said Doran Fink, Moderna’s clinical therapeutic area head for gastrointestinal and bacterial pathogens.
“I don’t know if it’s directly attributable to the increased incidence of norovirus this season, but we clearly have a lot of interest in participation in this trial,” Fink said.
Norovirus is a nasty stomach bug that causes vomiting and diarrhea. It’s highly contagious…
